Francisco Javier
López Jiménez
Profesor/a Asociado/a en CC. de la Salud
Memorial Sloan Kettering Cancer Center
Nueva York, Estados UnidosPublications in collaboration with researchers from Memorial Sloan Kettering Cancer Center (2)
2022
-
IBCL-271 Primary Efficacy and Safety Analysis of a Global Phase II Study of Zandelisib Administered by Intermittent Dosing (ID) in Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL): The TIDAL Study
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S387-S388
2021
-
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies
Blood, Vol. 138, Núm. 18, pp. 1768-1773